MedTrace Logo

A Clinical Evaluation for Tattoo Removal

NCT02756806 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-02-21

Study results available
· View outcomes & findings →

Summary

Evaluate safety and efficacy with the enlighten laser for tattoo removal.

Conditions

  • Tattoo Removal

Interventions

DEVICE

Picosecond Q-switched laser

Each subject will receive laser treatments with Enlighten laser

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Lourdes Moldre, NP · Cutera Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-09-28
Completion
2016-09-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756806 on ClinicalTrials.gov